Vanda Pharmaceuticals (NQ: VNDA )

13.73 USD -0.25 (-1.79%)

Official Closing Price Updated: 4:05 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	482,700
Open	13.98
Bid (Size)	13.73 (133)
Ask (Size)	13.74 (40)
Prev. Close	13.98
Today's Range	13.45 - 14.04
52wk Range	7.120 - 15.35
Shares Outstanding	52,110,701
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

December 01, 2020

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved HETLIOZ® (tasimelteon) capsule and liquid formulations for the treatment...

Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results

October 28, 2020

- Q3 2020 Total net product sales of $60.3 million, a 1% increase compared to Q3 2019

Performance

YTD	+0.66%	+0.66%
1 Month	-0.58%	-0.58%
3 Month	+31.14%	+31.14%
6 Month	+23.69%	+23.69%
1 Year	-8.41%	-8.41%

More News

Sum Up The Parts: IHE Could Be Worth $208

December 24, 2020

Here's Why Vanda Pharmaceuticals Jumped Higher Today

December 02, 2020

How The Parts Add Up: XSVM Targets $34

November 16, 2020

The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions

November 29, 2020

Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates

November 28, 2020

Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2021

January 14, 2021

Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace

December 06, 2020

62 Biggest Movers From Yesterday

December 03, 2020

56 Stocks Moving In Wednesday's Mid-Day Session

December 02, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.